BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38115222)

  • 41. Upregulation of PIR gene expression induced by human papillomavirus E6 and E7 in epithelial oral and cervical cells.
    Carrillo D; Muñoz JP; Huerta H; Leal G; Corvalán A; León O; Calaf GM; Urzúa U; Boccardo E; Tapia JC; Aguayo F
    Open Biol; 2017 Nov; 7(11):. PubMed ID: 29118270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paiteling induces apoptosis of cervical cancer cells by down-regulation of the E6/E7-Pi3k/Akt pathway: A network pharmacology.
    Liu Y; Zheng P; Jiao T; Zhang M; Wu Y; Zhang X; Wang S; Zhao Z
    J Ethnopharmacol; 2023 Apr; 305():116062. PubMed ID: 36535331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-risk HPV E5-induced cell fusion: a critical initiating event in the early stage of HPV-associated cervical cancer.
    Gao P; Zheng J
    Virol J; 2010 Sep; 7():238. PubMed ID: 20846406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells.
    Zhang X; Zhang A; Zhang X; Hu S; Bao Z; Zhang Y; Jiang X; He H; Zhang TC
    Virus Res; 2021 Dec; 306():198602. PubMed ID: 34662680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Metformin on the virus/host cell crosstalk in human papillomavirus-positive cancer cells.
    Hoppe-Seyler K; Herrmann AL; Däschle A; Kuhn BJ; Strobel TD; Lohrey C; Bulkescher J; Krijgsveld J; Hoppe-Seyler F
    Int J Cancer; 2021 Sep; 149(5):1137-1149. PubMed ID: 33844847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.
    Morgan EL; Macdonald A
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32899142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair.
    Bruyere D; Roncarati P; Lebeau A; Lerho T; Poulain F; Hendrick E; Pilard C; Reynders C; Ancion M; Luyckx M; Renard M; Jacob Y; Twizere JC; Peiffer R; Peulen O; Delvenne P; Hubert P; McBride A; Gillet N; Masson M; Herfs M
    Theranostics; 2023; 13(3):1130-1149. PubMed ID: 36793865
    [No Abstract]   [Full Text] [Related]  

  • 48. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer.
    Zhang JJ; Cao XC; Zheng XY; Wang HY; Li YW
    J Int Med Res; 2018 Mar; 46(3):1033-1042. PubMed ID: 29322839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TBX3 Promotes Cervical Cancer Proliferation and Migration via HPV E6 and E7 Signaling.
    Khan SF; Burmeister CA; Scott DJ; Sinkala M; Ramburan A; Wu HT; Schäfer G; Katz AA; Prince S
    Mol Cancer Res; 2023 Apr; 21(4):345-358. PubMed ID: 36622795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
    Callejas-Valera JL; Iglesias-Bartolome R; Amornphimoltham P; Palacios-Garcia J; Martin D; Califano JA; Molinolo AA; Gutkind JS
    Carcinogenesis; 2016 Oct; 37(10):1014-25. PubMed ID: 27538837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploitation of ATP-sensitive potassium ion (K
    Scarth JA; Wasson CW; Patterson MR; Evans D; Barba-Moreno D; Carden H; Cassidy R; Whitehouse A; Mankouri J; Samson A; Morgan EL; Macdonald A
    Oncogene; 2023 Aug; 42(34):2558-2577. PubMed ID: 37443304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
    Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and characterization of HPV-independent cervical cancers.
    Banister CE; Liu C; Pirisi L; Creek KE; Buckhaults PJ
    Oncotarget; 2017 Feb; 8(8):13375-13386. PubMed ID: 28077784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPV-associated cancers: insights into the mechanistic scenario and latest updates.
    Mukherjee AG; Ramesh Wanjari U; Valsala Gopalakrishnan A; Jayaraj R; Katturajan R; Kannampuzha S; Murali R; Namachivayam A; Evan Prince S; Vellingiri B; Dey A; Renu K
    Med Oncol; 2023 Jun; 40(8):212. PubMed ID: 37358816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Epithelial-Mesenchymal Transition via STAT3 Signaling Pathway in Non-Small Cell Lung Cancer Cells.
    Zhang W; Wu X; Hu L; Ma Y; Xiu Z; Huang B; Feng Y; Tang X
    Oncol Res; 2017 May; 25(5):843-852. PubMed ID: 28508744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EGFR-induced suppression of HPV E6/E7 is mediated by microRNA-9-5p silencing of BRD4 protein in HPV-positive head and neck squamous cell carcinoma.
    Nantajit D; Presta L; Sauter T; Tavassoli M
    Cell Death Dis; 2022 Nov; 13(11):921. PubMed ID: 36333293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding the HPV associated cancers: A comprehensive review.
    Balhara N; Yadav R; Ranga S; Ahuja P; Tanwar M
    Mol Biol Rep; 2024 Jun; 51(1):743. PubMed ID: 38874682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women.
    Rodrigues LC; Speck NM; Focchi GR; Schimidt MA; Marques RM; Ribalta JC
    Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human papillomavirus and molecular considerations for cancer risk.
    Whiteside MA; Siegel EM; Unger ER
    Cancer; 2008 Nov; 113(10 Suppl):2981-94. PubMed ID: 18980282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.